CNBM (03323): Tianshan Materials (000877.SZ) reported a net loss attributable to shareholders of 3.193 billion yuan in the first half of the year, a year-on-year increase of 245.51%.

22:28 25/08/2026

China National Building Material (03323) announced that its subsidiary Tianshan Materials (000877.SZ) achieved an operating revenue of 30.16 billion yuan for the six months ending June 30, 2026, a year-on-year decrease of 16.18%; the net loss attributable to shareholders of Tianshan Materials was 3.193 billion yuan, a year-on-year increase of 245.51%; basic earnings per share were a loss of 0.449 yuan.

CNBM (03323) announced that its subsidiary Tianshan Materials (000877.SZ) recorded an operating income of 30.16 billion yuan for the six months ending June 30, 2026, a year-on-year decrease of 16.18%; the net loss attributable to the shareholders of Tianshan Materials was 3.193 billion yuan, a year-on-year increase of 245.51%; basic loss per share was 0.449 yuan.

MANULIFE-S (00945) will distribute a second-quarter dividend of CAD 0.485 per share on September 21.

BRETON (01333) expects to incur a loss of approximately 80 million to 90 million yuan in the medium term, narrowing by about 45.93% to 51.67% compared to the same period last year.

AKESO (09926): The AK112309/HARMONi-GI1 Phase III clinical trial achieved statistically significant positive results in overall survival (OS) when comparing the efficacy of Abraxane combined with gemcitabine to that of Atezolizumab combined with chemotherapy, indicating substantial clinical benefits.

MANULIFE-S (00945) will distribute a second-quarter dividend of CAD 0.485 per share on September 21.

BRETON (01333) expects to incur a loss of approximately 80 million to 90 million yuan in the medium term, narrowing by about 45.93% to 51.67% compared to the same period last year.